Cologne, Germany / Basel, Switzerland, April 28th, 2015 – Lonza has today released CytoSMART™ System, an easy-to-use and affordable live cell imaging system that enables researchers to take time-lapse videos and images of their cell culture without needing to manually inspect their cells. The images taken with the CytoSMART™ Device are transmitted into the cloud, enabling researchers to view their cell culture outside of the actual cell culture lab at any given time through a web browser, whether via a computer, tablet or smartphone.
CytoSMART™ System offers a number of benefits to researchers, including 24 hour peace of mind that their cells are safe and well, all without them ever having to step foot in the lab. It also provides a number of advanced functions, such as reporting ongoing cell confluency via a graphical readout, while automatic email alerts can be set to inform the user when milestones are reached (for example, once the cell culture has reached a certain confluency). Everything is pulled together via one intuitive and easy to use interface, the CytoSMART™ Connect Cloud Project page, which allows users to view and download all the videos and images connected with their project.
“Researchers that have tested the CytoSMART™ Prototype have used it for a variety of different applications, such as cell culture monitoring and documentation, migration and scratch assays and cell culture standardization. Stem cell researchers were specifically interested in documenting the generation of induced pluripotent stem cells via video recordings, while labs that grow cells under hypoxic or GMP conditions greatly appreciated the ability to remotely monitor their cell cultures,” stated Herbert Mueller-Hartmann, Head of R&D at Lonza Bioscience Solutions.
“As the standard determination of cell culture confluency is through visual inspection, which is highly user dependent, many labs also valued the email alert functionality. This allows users to be notified once a culture had reached a certain confluency, saving them from manually checking their cells until absolutely necessary,” he continued.
Lonza has introduced the CytoSMART™ System as part of a global distribution agreement with CytoMate Technologies BV. As a leading supplier of primary and stem cell solutions, the CytoSMART™ Technology is a perfect addition to Lonza’s existing product portfolio.
For more information please visit www.lonza.com/cytosmart.
About Lonza Pharma&Biotech ?? Bioscience Solutions
Lonza provides the pharma market with the tools life science researchers use to develop and test therapeutics, from basic research to final product release. Lonza’s bioscience products and services range from cell culture and discovery technologies for research, to quality control tests and software to ensure product quality. Lonza Bioscience Solutions serves research customers worldwide in pharmaceutical, biopharmaceutical, biotechnology and personal care companies, as well as academic and government research institutions. The company delivers physiologically relevant cell biology solutions, and complete solutions for rapid microbiology. Primary brands include BioWhittaker™, Clonetics™, FlashGel™, MetaPhor™, MycoAlert™, Nucleofection™, NuSieve™, PAGEr™, Poietics™ and SeaKem®.
About Lonza
Lonza is one of the world’s leading and most-trusted suppliers to the pharmaceutical, biotech and specialty ingredients markets. We harness science and technology to create products that support safer and healthier living and that enhance the overall quality of life.
Not only are we a custom manufacturer and developer, Lonza also offers services and products ranging from active pharmaceutical ingredients and stem-cell therapies to drinking water sanitizers, from the vitamin B compounds and organic personal care ingredients to agricultural products, and from industrial preservatives to microbial control solutions that combat dangerous viruses, bacteria and other pathogens.
Founded in 1897 in the Swiss Alps, Lonza today is a well-respected global company with more than 40 major manufacturing and R&D facilities and approximately 9,800 employees worldwide. The company generated sales of about CHF 3.64 billion in 2014 and is organized into two market-focused segments: Pharma&Biotech and Specialty Ingredients. Further information can be found at www.lonza.com.
About CytoMate Technologies
CytoMate Technologies BV was founded to address a compelling need of life scientists to get more ‘real time’ information about the biological cell culture process. Researchers working in a cell culture lab love the information provided by time-lapse microscopes, but too few have a time-lapse microscope in their lab. The application of time-lapse microscopy is limited due to the cost of the instrument, complexity of the software, effort required for maintenance, and the large amount of bench space required for the instrument.
CytoMate Technologies offers an innovative, easy-to-use and affordable solution. Enabling everyone in life science to benefit from time-lapse microscopy. CytoMate Technologies BV is a privately owned innovative company with headquarters in The Netherlands. Further information can be found at www.cytomate.com.
Lonza Group Ltd
Head Investor Relations
Dirk Oehlers
Tel +41 61 316 8540
Fax +41 61 316 9540
dirk.oehlers@lonza.com
Lonza Group Ltd
Head Corporate Communications
Dominik Werner
Tel +41 61 316 8798
Fax +41 61 316 9540
dominik.werner@lonza.com
Lonza Group Ltd
Head External Communications
Constance Ward
Tel +41 61 316 8840
Fax +41 61 316 9840
constance.ward@lonza.com
Help employers find you! Check out all the jobs and post your resume.
